Business
GB Sciences Obtains Exclusive Worldwide License on a Time-Released Cannabinoid Formulation for Neuropathic Pain
GB Sciences Obtains Exclusive Worldwide License on a Time-Released Cannabinoid Formulation for Neuropathic Pain.
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n\n\n\nGB Sciences Obtains Exclusive Worldwide License on a Time-Released Cannabinoid Formulation for Neuropathic Pain\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGB Sciences Obtains Exclusive Worldwide License on a Time-Released Cannabinoid Formulation for Neuropathic Pain\nPR Newswire\nLAS VEGAS, Oct. 17, 2017\n\n\n\nLAS VEGAS, Oct. 17, 2017 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) has obtained the exclusive worldwide license to intellectual property covering a time-released cannabinoid formulation from the Universidad de Seville (\"USE\"), the Universidad de Cadiz (\"UCA\"), and the Centro de Investigación Biomédica en Red de Salud Mental (\"CIBERSAM\"). \n\n\n \n \n\n \n\"GB Sciences recognizes the ineffectiveness of current delivery methods for cannabis-based medicines (i.e., smoking, vaping, sublingual, and ingestion), and therefore licensed this innovative new cannabinoid nanotechnology from the University of Seville,\" explained Dr. Andrea Small-Howard, Chief Science Officer. \"Dr. Mercedes Fernández Arévalo and Dr. Lucía Martín Banderas are leading the industry in the development of nanotechnology delivery systems.\"\n\nIn collaboration with Dr. Juan A. Micó and Dr. Esther Berrocoso (UCA and CIBERSAM), this group of researchers from USE demonstrated that their time-released cannabinoid formulation provided relief from neuropathic pain in rats for eleven days from one orally-administered dose, as recently published in the journal Nanomedicine: Nanotechnology, Biology, and Medicine (http://www.sciencedirect.com/science/article/pii/S1549963417301405). \n\nTheir creation of an orally-administrated, time-released cannabinoid formulation used nanotechnology to encapsulate the medicine within a polymeric matrix to: 1) avoid digestion of the active ingredients; 2) target their absorption; 3) prolong blood circulation; and 4) provide a slow and steady release of active molecules. In addition, the active ingredients do not cross the blood brain barrier, which eliminates any possible psychoactive effects.\n\n\"We are exci...